Skip to main content

Table 5 Summary of adverse events

From: Effect of sitagliptin on blood glucose control in patients with type 2 diabetes mellitus who are treatment naive or poorly responsive to existing antidiabetic drugs: the JAMP study

Hypoglycemia

3

Hyperglycemia

1

Hematopoietic disorders

3

Cardiovascular disease

8

Respiratory disorders

2

Skin eruption

2

Gastrointestinal disorders

5

Hepatobiliary disorders

7

Renal and urinary disorders

2

Neuropsychiatric disorders

2

Others

20

Total

55